Sandy Cove Advisors’s Anterix ATEX Stock Holding History

Sandy Cove Advisors’s Portfolio ATEX Stock Details ATEX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-2,000	Closed	-$116K	–	94
2022 Q1	$116K	Hold	2,000	–	–	0.1%	117
2021 Q4	$118K	Buy	+2,000	New	+$121K	0.1%	105

Other funds holding ATEX

OCAM

Owl Creek Asset Management New York $1.21B AUM 169.99% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

HCL

Heard Capital LLC Chicago, Illinois $2.34B AUM 46.76% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Stonehill Capital Management New York $350M AUM 73.6% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCC

Bain Capital Credit Boston, Massachusetts $368M AUM 9.33% 1-Year Est. Return

JCP

Jennifer C. Price $75.5M AUM 6.25% 1-Year Est. Return

QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Sandy Cove Advisors's ATEX Position: Q2 2022 in Review

Sandy Cove Advisors sold out of Anterix (ATEX) in Q2 2022, closing a stake of 2,000 shares — an estimated $116K sold.

Sandy Cove Advisors first reported a position in ATEX in Q4 2021 and held it in 2 quarters. The position peaked at $118K in Q4 2021. 94 funds tracked by Wall St. Rank hold ATEX as of Q2 2022.

Sandy Cove Advisors reported no remaining Anterix position as of Q2 2022 after selling out during the quarter.
Sandy Cove Advisors sold 2,000 Anterix shares in Q2 2022, an estimated $116K.
Sandy Cove Advisors first reported a position in Anterix in Q4 2021 and held it in 2 quarters.
Sandy Cove Advisors's Anterix position peaked at $118K in Q4 2021.
94 funds tracked by Wall St. Rank held Anterix as of Q2 2022.

Based on Sandy Cove Advisors's 13F filing for Q2 2022, filed 11 Aug 2022.